Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia
Clinical trial NCT00086086 · COMPLETED
Trial details
- NCT number
- NCT00086086
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.